MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 25.78
-0.16 (-0.62%)
Aug 3, 2026, 12:36 PM CET
MedinCell Employees
MedinCell had 140 employees as of March 31, 2026. The number of employees increased by 9 or 6.87% compared to the previous year.
Employees
140
Change
9
Growth
6.87%
Revenue / Employee
€173,407
Profits / Employee
€223,479
Market Cap
931.35M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 140 | 9 | 6.87% |
| Mar 31, 2025 | 131 | -3 | -2.24% |
| Mar 31, 2024 | 134 | 3 | 2.29% |
| Mar 31, 2023 | 131 | -8 | -5.76% |
| Mar 31, 2022 | 139 | 1 | 0.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| DBV Technologies | 170 |
| Innate Pharma | 164 |
| Genfit | 161 |
| Transgene | 145 |
| Nanobiotix | 100 |
| ABIVAX Société Anonyme | 80 |
MedinCell News
- 4 days ago - Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook - Business Wire
- 6 days ago - Medincell Continues to Strengthen and Renew its Board of Directors with the Proposed Appointment of Dr. Elisabeth Svanberg - Business Wire
- 18 days ago - Medincell Aligns Debt Maturity with Its Expected Revenue Growth Trajectory - Business Wire
- 6 weeks ago - MedinCell Slides: Corporate presentation - Filings
- 6 weeks ago - MedinCell Transcript: H2 25/26 - Transcripts
- 6 weeks ago - MedinCell Earnings release: H2 2026 - Filings
- 6 weeks ago - MedinCell Slides: H2 2026 - Filings
- 6 weeks ago - Medincell Reports FY 2025-26 Annual Results - Business Wire